MPN Advocates Network (MPN AN) operates for the benefit of MPN patients and acts independently of any other organization or company. The organisation is constituted as an independent steering committee within a parent organisation, the Leukaemia Patient Advocates Foundation, registered as a non-profit organisation in Switzerland. MPN AN has it’s own scientific advisory board.
The mission of the MPN Advocates Network is to enhance the ability of global patient advocacy organizations to improve:
- Patient care
- Quality of life
- Patient empowerment
for all patients who have been diagnosed with myeloproliferative neoplasms (MPN) and their caregivers.
Our vision, quite simply, is a world without MPNs.
MPN AN receives support from a broad base of sponsors and diversified funding sources. Our funding for the activities comes from the variety of sources including pharmaceutical companies and philanthropy.
– Steering Committee –
Friends of Max, India
Gruppo AIL Pazienti LMC, Italy
Lyat Granati Espinosa
Max Foundation, Chile
MPN Voice, UK
LePaf Representative and Israeli Flute of Light
Patients Organization, Israel
MPN Alliance, Australia
MPN Research Foundation, USA
Croatian Leukemia and Lymphoma Society (HULL), Croatia
– Management Team –